NCT07495709

Brief Summary

The goal of this observational study is to assess the link between reactions to orofacial stimuli observed at 29 weeks of amenorrhoea, and feeding difficulties at 36 weeks of amenorrhoea, in babies born prematurely between 26 and 27 + 6 weeks of gestation, admitted to the CHSF between 1 May 2025 and 31 March 2026. The main questions it aims to answer are : Can reactions to orofacial stimulation in babies born very prematurely be used as a tool for early detection of feeding difficulties before discharge from hospital? Is it possible to establish a predictive score for potential feeding difficulties as early as 29 weeks of gestation corrected, based on reactions to orofacial stimuli ? Participants will have their reactions to orofacial stimulations recorded in the 'Suivi oralité' grid completed by the nurses in the neonatal medicine and intensive care unit, which will then collect.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Apr 2026Dec 2026

First Submitted

Initial submission to the registry

March 18, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

9 months

First QC Date

March 18, 2026

Last Update Submit

March 24, 2026

Conditions

Keywords

prematureEarly interventionorofacial stimulationfeeding difficultiesorality

Outcome Measures

Primary Outcomes (1)

  • Enteral nutrition

    Necessity for newborns to be fed exclusively by enteral nutrition at 36 weeks' gestation for at least 24 hours, percentage of milk volume taken orally at 36 weeks' gestation compared to prescription, average duration of bottle feeding at 36 weeks' gestation

    at 36 weeks

Study Arms (1)

Preterm infants

Preterm infants born between 26 and 27+6 weeks of gestation

Other: Oro-facial stimulation

Interventions

massages and sensory stimulation aimed at stimulating the oral-facial reflexes of newborns (hand-to-mouth connection, cardinal points, milk smell, digging, crushing (finger or teat), sucking (crushing + suction))

Preterm infants

Eligibility Criteria

Age26 Weeks - 28 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Premature babies hospitalised at the CHSF in neonatal resuscitation or intensive care units

You may qualify if:

  • Premature babies born between 26 and 27 + 6 weeks of gestation
  • Admitted to the CHSF between 1 May 2025 and 31 March 2026
  • Criteria grid completed upon admission
  • Parents or guardians informed of the study and not opposed to it.

You may not qualify if:

  • ENT malformation
  • Neurological pathology
  • Dysplasia or oxygen therapy greater than or equal to 0.3L/min (these children are seen systematically)
  • Extreme prematurity (gestational age less than 26 weeks)
  • Genetic syndrome
  • Anoxic-ischaemic encephalopathy
  • Digestive malformation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France, 91100, France

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Hasinirina RAZAFIMAHEFA, MD

    Centre Hospitalier Sud Francilien

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hasinirina Hasinirina RAZAFIMAHEFA, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2026

First Posted

March 27, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations